AltaThera Pharmaceuticals Overview
- Founded
- 2012
- Status
- Private
- Employees
- 12
- Latest Deal Type
- Angel
- Latest Deal Amount
- $1.53M
- Investors
- 1
AltaThera Pharmaceuticals General Information
Description
Provider of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult Atrial Fibrillation patients with effective treatments. The company's product focuses on critical care and alternative therapeutics for unmet medical needs, enabling medical organizations to use effective treatment for severe disorders and improve patient's lives.
Contact Information
Primary Industry
Pharmaceuticals
Primary Office
- 311 South Wacker Drive
- Suite 2275A
- Chicago, IL 60606
- United States
+1 (312) 000-0000
AltaThera Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Angel (individual) | 21-Aug-2019 | $1.53M | 00.000 | Completed | Generating Revenue | |
| 4. Angel (individual) | 22-Dec-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 3. Angel (individual) | 31-Jul-2015 | 000 | 00.00 | Completed | Generating Revenue | |
| 2. Angel (individual) | 03-Feb-2015 | $1.5M | $1.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 28-Oct-2014 | Completed | Generating Revenue |
AltaThera Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of specialty pharmaceuticals intended to serve pediatric cardiac patients and adult Atrial Fibrillation patient
Pharmaceuticals
Chicago, IL
12
As of 2019
00.000
0000000000
00.000
00000000
didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000 000000000
Sunnyvale, CA
0
As of 0000
00.000
00000000000
00.000
0000000
n ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
000000000000000
Dallas, TX
00
As of 0000
00000
0.000
0000-00-00
000000&0
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAltaThera Pharmaceuticals Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Altravax | Formerly VC-backed | Sunnyvale, CA | 0 | 00.000 | 00000000000 | 00.000 |
| 0000000 0000000000 | Formerly VC-backed | Dallas, TX | 00 | 00000 | 000000&0 | 00000 |
| 0000000000 | Corporate Backed or Acquired | Basel, Switzerland | 000000&0 | |||
| 0000000000 | Corporate Backed or Acquired | Baton Rouge, LA | 000000000000 | |||
| 0000000000 | Venture Capital-Backed | Oxford, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
AltaThera Pharmaceuticals Patents
AltaThera Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200253903-A1 | Method of initiating and escalating sotalol hydrochloride dosing | Pending | 14-Apr-2020 | 000000000 | |
| US-20210283049-A1 | Intravenous sotalol hydrochloride loading and maintenance for cardiac surgery patients | Pending | 10-Mar-2020 | 00000000 | |
| US-20200338027-A1 | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame | Pending | 10-Mar-2020 | 000000000 | |
| US-10512620-B1 | Method of initiating and escalating sotalol hydrochloride dosing | Active | 14-Aug-2018 | 000000000 | 00 |
| US-20200085771-A1 | Method of initiating and escalating sotalol hydrochloride dosing | Pending | 14-Aug-2018 | A61K31/18 |
AltaThera Pharmaceuticals Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jodi Devlin | Chief Executive Officer | ||
| Brandon Kashfian | Founder & Chief Business Officer | ||
| Stephen O'Sullivan JD | Director, Chief Compliance Officer & General Counsel |
AltaThera Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAltaThera Pharmaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Matter Ventures | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |